Discover FDA programs in 2026 that foster rare disease drug development, offering guidance, funding, and regulatory support for innovators.
Focusing on Rare Disease
Rare diseases present unparalleled challenges for patients. At Alira Health, we help companies develop and commercialize rare disease treatments with intense focus on the unique needs of rare disease patients that is crucial to your success. With a continuum of patient-centric solutions, we work with you to successfully develop and provide life-changing treatments to the patients. From clinical trial patient recruitment and retention to crafting a patient-centric product strategy, our transversal team stands by you every step of the way.
Rare diseases present unparalleled challenges for patients. At Alira Health, we help companies develop and commercialize rare disease treatments with intense focus on the unique needs of rare disease patients that is crucial to your success. With a continuum of patient-centric solutions, we work with you to successfully develop and provide life-changing treatments to the patients. From clinical trial patient recruitment and retention to crafting a patient-centric product strategy, our transversal team stands by you every step of the way.
Rare Disease Expert Materials
On this page, we gathered our key publications that contribute to understanding and innovation in the field. Explore the latest insights and join the movement to raise awareness and drive progress. Contact us if you are looking for support.
Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.
Explore how registries in rare disease trial recruitment connect sponsors with patient communities to improve identification and enrollment.
Discover best practices for designing payer communications with patient-informed value at the centre.
Explore how dual branding in rare diseases and oncology drives growth, ensures regulatory compliance, and supports market access and brand differentiation.
Learn how systematic patient engagement drives success in rare disease drug development. Read now to enhance your strategy, outcomes, and patient impact.